npj Metabolic Health and Disease · Published 2026-07-29 · DOI 10.1038/s44324-026-00123-3
Karthik Shree Harini, Devaraj Ezhilarasan
Metabolic dysfunction-associated steatotic liver disease (MASLD) in India demonstrates marked regional variation influenced by metabolic risk, lifestyle transition, and population-specific susceptibility. This commentary highlights the growing burden of lean MASLD, the importance of visceral adiposity and cardiometabolic dysfunction, and population-specific genetic influences in Indian populations. Given the close association between MASLD and type 2 diabetes, region-specific prevention, early risk assessment, and integrated metabolic care strategies are increasingly important.
Abstract from DOAJ. Public domain (CC0 1.0).
Read the article at the publisher →
Harini, K., Ezhilarasan, D. (2026). Understanding regional differences in MASLD: the Indian perspective. npj Metabolic Health and Disease. https://doi.org/10.1038/s44324-026-00123-3